Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine TumorsMAIRE, Frédérique; HAMMEL, Pascal; RUSZNIEWSKI, Philippe et al.Neuroendocrinology (Basel). 2009, Vol 90, Num 1, pp 67-72, issn 0028-3835, 6 p.Article

Cooperative function of Chk1 and p38 pathways in activating G₂ arrest following exposure to temozolomideHIROSE, Yuichi; KATAYAMA, Makoto; BERGER, Mitchel S et al.Journal of neurosurgery. 2004, Vol 100, Num 6, pp 1060-1065, issn 0022-3085, 6 p.Article

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingPAYNE, M. J; PRATAP, S. E; MIDDLETON, M. R et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 241-252, issn 1040-8428, 12 p.Article

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMTBROWN, Chad C; HAVENER, Tammy M; MEDINA, Marisa W et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 11, pp 796-802, issn 1744-6872, 7 p.Article

INHIBITION OF METALLOPROTEINASES DERIVED FROM TUMOURS: NEW INSIGHTS IN THE TREATMENT OF HUMAN GLIOBLASTOMAGABELLONI, P; DA POZZO, E; BENDINELLI, S et al.Neuroscience. 2010, Vol 168, Num 2, pp 514-522, issn 0306-4522, 9 p.Article

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in GliomaLI, Rui-Yan; CHEN, Ling-Chao; YANG, Dong-Bo et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 7, pp 477-483, issn 1755-5930, 7 p.Article

In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent TemozolomideWHOON JONG KIL; CERNA, David; BURGAN, William E et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 931-938, issn 1078-0432, 8 p.Article

Chemotherapy-Associated Steatohepatitis with Temozolomide and DexamethasoneMILLER, Robert J. H; XIANYONG GUI; EASAW, Jacob C et al.Canadian journal of neurological sciences. 2012, Vol 39, Num 4, pp 547-549, issn 0317-1671, 3 p.Article

Treatment of Nelson's syndrome with temozolomideMOYES, V. J; ALUSI, G; SABIN, H. I et al.European journal of endocrinology. 2009, Vol 160, Num 1, pp 115-119, issn 0804-4643, 5 p.Article

Evaluation of the exposure equivalence of oral versus intravenous temozolomideDIEZ, Blanca D; STATKEVICH, Paul; OTTAVIANO, Fabio H et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 727-734, issn 0344-5704, 8 p.Article

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumoursBARUCHEL, S; DIEZI, M; HARGRAUE, D et al.European journal of cancer (1990). 2006, Vol 42, Num 14, pp 2335-2342, issn 0959-8049, 8 p.Article

A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasPANETTA, John Carl; KIRSTEIN, Mark N; GAJJAR, A. J et al.Mathematical biosciences. 2003, Vol 186, Num 1, pp 29-41, issn 0025-5564, 13 p.Article

Chemotherapy for diffuse low-grade gliomas in adultsDUCRAY, F.Revue neurologique (Paris). 2011, Vol 167, Num 10, pp 673-679, issn 0035-3787, 7 p.Conference Paper

Analysis and stability study of temozolomide using capillary electrophoresisANDRASI, Melinda; BUSTOS, Rose; GASPAR, Attila et al.Journal of chromatography. B. 2010, Vol 878, Num 21, pp 1801-1808, issn 1570-0232, 8 p.Article

Potentiation of antiglioma effect with combined temozolomide and interferon-βPARK, Jin-A; JOE, Young-Ae; KIM, Tai-Gyu et al.Oncology reports. 2006, Vol 16, Num 6, pp 1253-1260, issn 1021-335X, 8 p.Article

Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTICKIRSTEIN, Mark N; PANETTA, John C; GAJJAR, Amar et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 5, pp 433-438, issn 0344-5704, 6 p.Article

Effect of temozolomide on cell viability in gonadotroph adenoma cell linesSIHAI MA; XIAOHAI LIU; WENBIN MA et al.Oncology reports. 2011, Vol 26, Num 3, pp 543-550, issn 1021-335X, 8 p.Article

Prolonged Administration of Temozolomide in Adult Patients with Anaplastic GliomaFREYSCHLAG, C. F; SMOLCZYK, D. R; JANZEN, E et al.Anticancer research. 2011, Vol 31, Num 11, pp 3873-3877, issn 0250-7005, 5 p.Article

Complications of a temozolomide overdose : a case reportSPENCE, Alexander M; KIEM, Hans-Peter; PARTAP, Sonia et al.Journal of neuro-oncology. 2006, Vol 80, Num 1, pp 57-61, issn 0167-594X, 5 p.Article

Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanomaHWU, Wen-Jen; PANAGEAS, Katherine S; HOUGHTON, Alan N et al.Cancer. 2006, Vol 106, Num 11, pp 2445-2451, issn 0008-543X, 7 p.Article

The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cellsRAVIZZA, Raffaella; CEREDA, Elena; MONTI, Elena et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1817-1822, issn 1019-6439, 6 p.Article

8-Hydroxynaphthalene-1,4-dione derivative as novel compound for glioma treatmentZAGOTTO, Giuseppe; REDAELLI, Marco; PASQUALE, Riccardo et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 7, pp 2079-2082, issn 0960-894X, 4 p.Article

Pharmacokinetics of temozolomide administered in combination with O⁶-benzylguanine in children and adolescents with refractory solid tumorsMEANY, Holly J; WARREN, Katherine E; FOX, Elizabeth et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 137-142, issn 0344-5704, 6 p.Article

Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité: exemple du témozolomide = Unknown gonadotoxicity chemotherapy and preservation of fertility: Example of TemozolomideSITBON SITRUK, L; SANSON, M; PRADES, M et al.Gynécologie obstétrique & fertilité. 2010, Vol 38, Num 11, pp 660-662, issn 1297-9589, 3 p.Article

Carcinomes et adénomes hypophysaires agressifs: mise au point et nouvelles options thérapeutiques = Pituitary carcinomas and aggressive adenomas: an overview and new therapeutic optionsMAÏZA, J.-C; CARON, Ph.Annales d'endocrinologie. 2009, Vol 70, issn 0003-4266, S12-S19, SUP1Article